Consolidated Statement Of Cash Flows

CHUGAI PHARMACEUTICAL CO., LTD. - Filing #7315166

Concept 2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
As at
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
As at
2023-12-31
2023-01-01 to
2023-06-30
As at
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
As at
2022-12-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
186,262,000,000 JPY
JPY
JPY
186,262,000,000 JPY
JPY
186,262,000,000 JPY
156,693,000,000 JPY
JPY
JPY
156,693,000,000 JPY
156,693,000,000 JPY
JPY
Other
3,488,000,000 JPY
-1,089,000,000 JPY
Subtotal
211,601,000,000 JPY
350,422,000,000 JPY
Income taxes paid
-40,038,000,000 JPY
-96,002,000,000 JPY
Net cash provided by (used in) operating activities
171,563,000,000 JPY
254,420,000,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-32,871,000,000 JPY
-45,233,000,000 JPY
Proceeds from sale of property, plant and equipment
-214,000,000 JPY
2,194,000,000 JPY
Purchase of intangible assets
-1,690,000,000 JPY
-1,439,000,000 JPY
Purchase of investment securities
-68,000,000 JPY
-219,000,000 JPY
Proceeds from sale of investment securities
JPY
340,000,000 JPY
Net cash provided by (used in) investing activities
-172,890,000,000 JPY
-44,926,000,000 JPY
Cash flows from financing activities
Proceeds from exercise of employee share options
94,000,000 JPY
155,000,000 JPY
Net cash provided by (used in) financing activities
-69,469,000,000 JPY
-69,647,000,000 JPY
Cash and cash equivalents
393,761,000,000 JPY
458,674,000,000 JPY
365,016,000,000 JPY
222,169,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
5,884,000,000 JPY
3,000,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.